Spectracure Ab
Clinical trials sponsored by Spectracure Ab, explained in plain language.
-
Light-activated therapy offers new hope for recurrent prostate cancer
Disease control Recruiting nowThis study tests a treatment that uses lasers and a light-sensitive drug to destroy cancer cells in the prostate without major surgery. It is for men whose prostate cancer has returned after radiation therapy and who cannot have surgery or more radiation. The goal is to see if th…
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Laser and Light-Sensitive drug aim to zap prostate cancer without surgery
Disease control Recruiting nowThis early-stage trial tests a new treatment for men with localized prostate cancer. It uses a light-sensitive drug called verteporfin, which is injected into the bloodstream and then activated by laser light delivered through thin fibers placed into the prostate. The goal is to …
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC